Olympic Ophthalmics Announces Issuance of Two Seminal Patents for its Neuromodulation Technology
Patents cover iTEAR’s unique neurostimulation pathways, device, and comfort features Olympic Ophthalmics, a leading neurostimulation medical device company, today announced that the U.S. Patent and Trademark Office has issued two seminal neuromodulation patents. These patents cover the unique neural target to activate the parasympathetic pathway through the trigeminal nerve. Modulation of this